Inhibitory effect of plasma obtained from hypophysectomized and control women on the assay of bioactive luteinizing hormone

Human Reproduction

Volumn 14, Issue 2, 1999, Pages 312-317

  Galeraud Denis, I ^a   Bouchard, P ^b   Herlicoviez, M ^a   Marie, E ^a   Carreau, S ^c  

^a CHU Clemenceau   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

Hypophysectomy; Inhibitory factors; LH bioactivity; Plasma

Indexed keywords

ETHER; GONADORELIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE ANTIBODY; MACROGOL; TESTOSTERONE;

ADULT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; FEMALE; GONADOTROPIN RELEASE; HORMONE DETERMINATION; HUMAN; HYPOPHYSECTOMY; IMMUNORADIOMETRIC ASSAY; LEYDIG CELL; MALE; NONHUMAN; PLASMA; RAT; TESTOSTERONE RELEASE;

ANIMALIA;

EID: 0032977536     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.2.312     Document Type: Article

References (28)

1. Boujrad, N., Denis, I., Papadopoulos, V. et al. (1991) Mise en évidence d'un (ou des) inhibiteur(s) de LH dans les sérums ovin et humain. C.R. Acad. Sci. Paris, 310, 417-421.
2. Denis, I., Drosdowsky, M.A. and Carreau, S. (1994) In vitro effects of various albumins on Leydig cell testosterone production in immature rat. Horm. Metab. Res., 26, 55-56.
3. Ding, Y.Q. and Huhtaniemi, I. (1989) Human serum LH inhibitor(s): behavior and contribution to in vitro bioassay of LH using dispersed mouse Leydig cells. Acta Endocrinol., 121, 46-54.
4. Ding, Y.Q., Ranta, T., Nikkanen, V. et al. (1991) Discordant concentrations of serum bioactive LH in man as measured in different in vitro bioassay systems using rat and mouse interstitial cells and human granulosa-luteal cells. J. Endocrinol., 128, 131-137.
5. Ding, Y.Q. and Huhtaniemi, I. (1991) Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immuno ratio of LH in healthy women and in women with polycystic ovarian disease. Hum. Reprod., 6, 346-350.
6. Dufau, M.L., Mendelson, C.R. and Catt, K.J. (1974) A highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin: testosterone production by dispersed Leydig cells. J. Clin. Endocrinol. Metab., 39, 610-613.
7. Dufau, M.L., Beitins, I.Z., McArthur, J.W. et al. (1976) Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH concentrations in normal subjects. J. Clin. Endocrinol. Metab., 43, 658-667.
8. Fauser, B.C.J.M., Pache, T.D., Lamberts, S.W.J. et al. (1991) Serum bioactive and immuno reactive luteinizing hormone and follicle-stimulating-hormone concentrations in women with cycle abnormalities, with or without polycystic ovarian disease. J. Clin. Endocrinol. Metab., 73, 811-817.
9. Furui, K., Suganuma, N., Tsukahara, S. et al. (1994) Identification of two point mutations in the gene coding luteinizing hormone (LH) β-subunit, associated with immunologically anomalous LH variants. J. Clin. Endocrinol. Metab., 78, 107-113.
10. Haavisto, A.M., Pettersson, K., Bergendahl, M. et al. (1995) Occurrence and biological properties of a common genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab., 80, 1257-1263.
11. Imse, V., Holzapfel, G., Hinney, B. et al. (1992) Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays. J. Clin. Endocrinol. Metab., 74, 1053-1061.
12. Jaakkola, T., Ding, Y.Q., Kellokumpu-Lehtinen, P. et al. (1990) The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay. J. Clin. Endocrinol. Metab., 70, 1496-1505.
13. Lichtenberg, V. and Pahnke, V.G. (1976) Measurement of biologically active LH/hCG by in vitro testosterone production assay and problems when applied to serum. Acta Endocrinol. Suppl., 202, 54-57.
14. Lichtenberg, V., Pahnke, V.G., Graesslin, D. et al. (1982) Biological and immunological potencies of lutropin (LH) in human serum: comparative studies using different standard preparations. Horm. Metab. Res., 14, 39-45.
15. Lobo, R.A., Kletzky, O.A., Campeau, J.D. et al. (1983) Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil. Steril., 39, 674-678.
16. Papadopoulos, V., Carreau, S. and Drosdowsky, M.A. (1985) Effects of phorbol ester and phospholipase C on LH-stimulated steroidogenesis in purified rat Leydig cells. FEBS Lett., 188, 312-316.
17. Papadopoulos, V., Kamtchouing, P., Boujrad, N. et al. (1990) Evidence of LH-inhibiting activity in ovine peripheral and testicular blood. Acta Endocrinol., 123, 345-352.
18. Rajalakshmi, M., Robertson, D.M., Choi, S.K. et al. (1979) Biologically active luteinizing hormone (LH) in plasma. III. Validation of the in vitro bioassay when applied to male plasma and the possible role of steroidal precursors. Acta Endocrinol., 90, 585-598.
19. Rajkhowa, M., Talbot, J.A., Jones, P.W. et al. (1995) Prevalence of an immunological LH β-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin. Endocrinol., 43, 297-303.
20. Revol, A., Carreau, S., Castanier, M. et al. (1997) Mesure de l'activité biologique de l'hLH: étude multicentrique. Ann. Biol. Clin., 55, 123-128.
21. Stanton, P.G., Burgon, P.G., Hearn, M.T.W. et al. (1996) Structural and functional characterisation of hFSH and hLH isoforms. Mol. Cell. Endocrinol., 125, 133-141.
22. 15 → Thr) in human luteinizing hormone (LH) β-subunit on LH bioactivity in vitro and in vivo. Endocrinology, 137, 831-838.
23. Van Damme, M.P., Robertson, D.M. and Diczfalusy, E. (1974) An improved in vitro bioassay method for measuring luteinizing hormone activity using mouse Leydig cells preparations. Acta Endocrinol., 77, 655-671.
24. Veldhuis, J.D. and Dufau, M.L. (1993) Steroidal regulation of biologically active luteinizing hormone secretion in men and women. Hum. Reprod., 8 (suppl. 2), 84-96.
25. Whitcomb, R.W., Schneyer, A.L., Roser, J.F. et al. (1991) Circulating antagonist of luteinizing hormone in association with infertility in stallions. Endocrinology, 128, 2497-2502.
26. Wide, L., Lee, J.Y. and Rasmussen, C. (1994) A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. J. Clin. Endocrinol. Metab., 78, 1419-1423.
27. Wide, L., Albertsson-Wikland, K. and Phillips, D.J. (1996) More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children. J. Clin. Endocrinol. Metab., 81, 216-221.
28. Zaidi, A.A., Qazi, M.H. and Diczfaluzy, E. (1982) Molecular composition of human luteinizing hormone: biological and immunological properties of highly purified preparations after electrofocusing. J. Endocrinol., 94, 29-36.